ArticleResearch square2026

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Niels von Wardenburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.